Attached files
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We
hereby consent to the reference to our firm under the caption
“Experts” and the use of our report dated March 24,
2017, which includes an explanatory paragraph regarding the
substantial doubt about the Company’s ability to continue as
a going concern, on the financial statements of ENDRA Life Sciences
Inc. which appears in this Registration Statement on Form S-1
Amendment No. 8.
/s/
RBSM LLP
Henderson,
NV
March
24, 2017